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Abstract
Werner syndrome (WS) is a premature aging disease caused by a
mutation in the WRN gene. The gene was identified in 1996 and its
product acts as a DNA helicase and exonuclease. Some specific WRN
polymorphic variants were associated with increased risk for cardio-
vascular diseases. The identification of genetic polymorphisms as risk
factors for complex diseases affecting older people can improve their
prevention, diagnosis and prognosis. We investigated WRN codon
1367 polymorphism in 383 residents in a district of the city of São
Paulo, who were enrolled in an Elderly Brazilian Longitudinal Study.
Their mean age was 79.70 ± 5.32 years, ranging from 67 to 97. This
population was composed of 262 females (68.4%) and 121 males
(31.6%) of European (89.2%), Japanese (3.3%), Middle Eastern
(1.81%), and mixed and/or other origins (5.7%). There are no studies
concerning this polymorphism in Brazilian population. These sub-
jects were evaluated clinically every two years. The major health
problems and morbidities affecting this cohort were cardiovascular
diseases (21.7%), hypertension (83.7%), diabetes (63.3%), obesity
(41.23%), dementia (8.0%), depression (20.0%), and neoplasia (10.8%).
Their prevalence is similar to some urban elderly Brazilian samples.
DNA was isolated from blood cells, amplified by PCR and digested
with PmaCI. Allele frequencies were 0.788 for the cysteine and 0.211
for the arginine. Genotype distributions were within that expected for
the Hardy-Weinberg equilibrium. Female gender was associated with
hypertension and obesity. Logistic regression analysis did not detect
significant association between the polymorphism and morbidity.
These findings confirm those from Europeans and differ from Japa-
nese population.
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Introduction
Werner syndrome (WS) or Adult Pro-
geria is a rare autosomal recessive disorder
characterized as a segmental progeroid syn-
drome (1). WS patients develop the appear-
ance of advanced aging in middle-age, in-
cluding age-related disorders usually seen in
normal elderly subjects, such as atheroscle-
rosis, diabetes mellitus, osteoporosis, and
neoplasias. The major cause of death is myo-
cardial infarction (1-5).
Positional cloning identified WRN as the
gene responsible for WS (6). The mutant
gene is a member of the RECQ family of
helicases together with catalytic and exonu-
clease activities, and its product probably
functions in basic types of DNA transac-
tions, such as replication, repair, recombina-
tion, and transcriptional and chromosomal
segregation. Recent studies also suggest that
RecQ helicases act as genome caretakers (7-
10).
Specific WRN polymorphisms have been
studied to understand the impact of molecu-
lar variants on longevity in WS as well as
other age-related disorders and can yield
new insights to its biological and pathologi-
cal role (3,4,8,11). The identification of ge-
netic polymorphisms as risk factors for com-
plex diseases in elderly people can be rel-
evant for their prevention, diagnosis and
prognosis.
An initial study of WRN:1367 polymor-
phism carried out in a Japanese population
showed that the homozygosity of cysteine
predicted a three-fold higher incidence of
myocardial infarction than in normal control
patients (11), a finding that was subsequently
confirmed by Morita et al. (12) in the same
population. The relatively homogeneous
Finnish population shows high rates of cor-
onary atherosclerosis and the putatively pro-
tective effect of the 1367 arginine (R) allele
has been investigated in centenarians in com-
parison with newborns. However, no sig-
nificant differences were observed between
the two age groups (3).
Population studies of WRN 1074 Leu/
Phe and 1367 Cys/Arg polymorphisms in
Finnish, Mexican and North American sub-
jects revealed only a tendency for the 1074
Phe allele to be associated with coronary
stenosis and that the 1367 Arg/Arg (RR)
genotype tended to protect against coronary
artery occlusion, although without statistical
significance (4).
The involvement of WRN:1367 polymor-
phism in age-associated disorders was ob-
served by Ogata et al. (13), who reported
lower bone density of the lumbar spine in
postmenopausal C allele-carrying Japanese
women. Long-term hemodialysis patients
also showed an association with this poly-
morphism (14).
In the present study, we investigated al-
lele frequencies and the association of
WRN:1367 polymorphism with major mor-
bidities that affect the elderly in a São Paulo,
Brazil, community. These people participate
in a longitudinal study of Brazilian elderly
individuals initiated in 1991. This is the first
longitudinal study in Brazil analyzing WRN:
1367 polymorphism in elderly people.
Material and Methods
Population
The study population consisted of 383
participants from the Elderly Longitudinal
Study (15). This study began in 1991 and
originally involved 1667 people older than
66 years living in a district of São Paulo,
Brazil. The mean age of this population was
79.80 ± 5.32 years (range: 66-97). Subjects
were evaluated clinically every two years
and a subsample of 383 in wave 4 (2000-
2001) was invited to participate in our study.
This population was composed of individu-
als of European origin (89.2%), Japanese
origin (3.3%), Middle Eastern origin (1.81%),
and mixed and/or other origin (5.70%).
Clinical inquiries were performed to ob-
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tain information about previous diseases,
current medication use, lifestyle, and an-
thropometric and blood pressure measure-
ments. We informed participants about the
study protocol. Physicians performed the
physical exam and blood was collected for
laboratory procedures.
Positivity for cardiovascular disease was
considered to be present when individuals
self-reported previous myocardial infarction,
coronary heart disease, transitory ischemic
attack or cerebrovascular disease, and were
taking specific medication prescribed by
physicians.
Those currently using anti-hypertensive
drugs or those with systolic blood pressure
above 140 or diastolic blood pressure above
95 mmHg were considered to be positive for
hypertension (16,17). Those currently tak-
ing insulin or oral medication and those with
fasting glucose equal to or above 126 mg/dl
were considered to be positive for type II
diabetes (18).
Positivity for neoplasia was considered
when individuals self-reported a previous
diagnosis with confirmation in their medical
record, which presented the results of histo-
logical examination among others.
Subjects with a body mass index above
27 kg/m2 (19,20) specifically for 65 years of
age and older were considered to be positive
for obesity.
Cognitive function was evaluated by the
Mini-Mental State Examination (MMSE)
screening instrument (21) validated for the
Brazilian population (22). An MMSE score
lower than 24 (out of 30) has 80-90% sensi-
tivity and 80% specificity for discriminating
individuals with low cognition level (roughly
classified as dementia) from normal subjects
(22,23). Depression was characterized by a
score above 5 in a validated Brazilian ver-
sion of the Older American’s Resources and
Services questionnaire (24).
Although some studies have shown that
self-reported past history and medical records
are usually concordant for selected medical
conditions in the elderly (25), past histories
were only accepted when there was also
evidence in physical examinations, ECG,
CT-scan, or physician reports.
The Research Ethics Committee of
UNIFESP approved this study and all par-
ticipants gave written informed consent ac-
cording to the Helsinki Declaration.
DNA extraction
Whole blood was collected into tubes
containing 0.1% EDTA and genomic DNA
was isolated according to Lahiri and
Nurnberger Jr. (26).
Genotyping
WRN:1367 polymorphism was analyzed
using the method of Ye et al. (11). A 193-bp
sequence containing the polymorphic site
was amplified by the polymerase chain reac-
tion (PCR) using the following primers:
sense: 5-'GCCTAATCAGAATGTTAGTT-
3', antisense: 5'-TCAGTATTGATGCCTAC
CTC-3'.
Each PCR preparation contained 50 ng
genomic DNA in 10% PCR buffer, 2 mM
MgCl, 0.2 mM dNTPs, 2.5 U Taq polymer-
ase, and 10 mM each primer. The mixture
was heated for 5 min at 95ºC and underwent
35 amplification cycles: annealing (55ºC for
30 s), extension (72ºC for 45 s) and denatur-
ation (94ºC for 45 s).
PCR products were incubated with PmaCI
restriction endonuclease and digestion was
performed for 3 h at 37ºC. Restriction frag-
ment length polymorphism products were
analyzed by 4% GTG agarose gel electro-
phoresis and then stained with ethidium bro-
mide. The C allele (cysteine) produces only
a 193-bp fragment, whereas the R allele
(arginine) produces two fragments, one of
101 bp and the other of 92 bp. Figure 1
shows the allele and genotype patterns.
The DNA markers were from Gibco BRL
Products (New York, NY, USA).
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Statistical analysis
Genotype and allele frequencies were
calculated as described by Emery (27). The
chi-square test was applied to determine if
genotype distributions were within Hardy-
Weinberg equilibrium.
Descriptive statistics and logistic regres-
sion analysis were performed considering
two allele groups: one with the presence of
the R allele (RR + CR genotypes together)
and the other with the absence of the R allele
(CC genotype) in view of the low frequency
of the RR genotype. The presence of mor-
bidity interactions was evaluated and signif-
icance was calculated by the chi-square test
(α = 0.05). Statistical analysis was performed
using SPSS 10.0 software.
The mean age of subjects with the pres-
ence of the R allele (RR and CR genotypes
together) was 80.05 ± 5.14 (range: 66-94
years) and the mean age of subjects with
absence of the R allele (CC genotype) was
79.64 ± 5.43 (range: 69-97 years). We used
t-test statistics to evaluate the two allele
groups in relation to age.
The odds ratios (OR) and 95% confi-
dence interval (95% CI) were calculated by
logistic regression analysis considering the
frequency among people with (presence) the
R allele compared to that among people
without (absence) the R allele. Morbidity,
sex and age were considered to be independ-
ent variables in the model. The adjusted OR
and 95% CI for morbidity interactions were
calculated by computing the exponential
value obtained by adding the regression co-
efficients for variable interactions and the
coefficients of the respective variable refer-
ence.
Results
The allele frequencies observed in our
population were 0.788 for the C allele and
0.211 for the R allele. The observed geno-
type frequencies were: CC = 0.608, CR =
0.36 and RR = 0.031. Genotype distribu-
tions were within Hardy-Weinberg equilib-
rium (data not shown). The comparison of
each allele group concerning age did not
show any significant difference (t = 0.73;
d.f. = 38 1; P = ns).
The use of descriptive statistics and of
the chi-square test showed a significant as-
sociation between the following morbidi-
ties: cardiovascular disorder and depression
(χ2 = 10.11; d.f. = 1; P < 0.01), diabetes and
neoplasia (χ2 = 7.38; d.f. = 1; P < 0.01),
dementia and depression (χ2 = 5.40; d.f. = 1;
P < 0.05), diabetes and obesity (χ2 = 6.67;
d.f. = 1; P < 0.01), and hypertension and
obesity (χ2 = 7.97; d.f. = 1; P < 0.01).
Table 1 shows the number and percent of
200 bp
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Figure 1. WRN :1367 gene polymorphism. A, PCR amplification products on 2% agarose gel. Lanes 1-8 (PCR products), C (negative control) and M
(DNA marker, 100 bp). B, Restriction fragment length polymorphism on 4% GTG agarose gel. Lanes 1, 2, 6, and 8, R allele and RR genotype (~101 +
~92 bp); lanes 3 and 7, C allele and CC genotype (~193 bp), and lanes 4 and 5, CR genotype (~199 + ~113 + ~86 bp) and M (DNA marker, 25 bp).
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subjects of each gender in relation to mor-
bidity. We observed a significant associa-
tion between female gender and hyperten-
sion (χ2 = 4.85; d.f. = 1; P < 0.05) as well as
obesity (χ2 = 6.21; d.f. = 1; P < 0.05).
Table 2 shows the number of subjects
with and without the R allele in relation to
sex, age and morbidity as well as the logistic
regression results. We did not find any sig-
nificant association between WRN polymor-
phism and morbidity, sex or age. The ad-
justed OR and 95% CI for morbidity interac-
tions were: 0.78 and 0.31-1.97 for cardio-
vascular disease and depression, 0.70 and
0.26-1.85 for diabetes and neoplasia, 1.03
and 0.27-3.95 for dementia and depression,
0.40 and 0.12-1.35 for hypertension and obe-
sity, and 0.99 and 0.22-4.43 for diabetes and
obesity, respectively. These results did not
indicate any significant association between
the polymorphism and morbidity.
Discussion
In the present study, we investigated the
WRN:1367 allele and genotype frequencies
as well as their association with major mor-
bidities affecting elderly people in a Brazil-
ian population sample ranging from 66 to 97
years of age.
Genotype distributions were within
Hardy-Weinberg equilibrium and did not
show any significant age-related effect suf-
ficient to alter gene frequency.
Table 2. Number of subjects with the presence or absence of the R allele in relation to sex, age and morbidity
and results of logistic regression analysis.
Variables Presence of Absence of No. of OR and 95% CI
R allele R allele valid cases (presence/absence of R allele)
No. Total No. Total OR Lower Upper
Sex (female/male) 103/47 150 159/74 233 383 0.958 0.565 1.624
Age (mean ± SD)  80.05 ± 5.14  79.64 ± 5.43 383 0.998 0.952 1.047
Cardiovascular disease 31 150 52 233 383 1.007 0.504 2.011
Diabetes type II 96 150 146 232 382 0.633 0.324 1.238
Hypertension 125 150 195 232 382 0.627 0.284 1.384
Obesity 54 119 73 189 382 0.567 0.096 3.340
Depression 29 149 42 216 354 1.047 0.460 2.383
Dementia 12 149 18 227 376 1.114 0.334 3.723
Neoplasia 16 149 25 229 378 0.527 0.050 5.598
OR = odds ratio; 95% CI = 95% confidence interval; SD = standard deviation.
Table 1. Number and percent of female and male subjects with or without each morbidity.
Disease Affected female (%) Female (total) Affected male (%) Male (total) Total number
Cardiovascular disease 50 (19.1) 262 33 (27.3) 121 383
Hypertension 226 (86.6) 261 94 (77.7)* 121 382
Diabetes type II 165 (63.2) 261 77 (63.6) 121 382
Dementia 22  (8.6) 257 8 (6.7) 119 376
Depression 54 (22.7) 238 17 (14.7) 116 354
Obesity 97 (45.9) 211 30 (30.9)* 97 308
Neoplasia 24 (9.3) 258 17 (14.2) 120 378
*P < 0.05 compared to the number of affected females (chi-square test).
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Our elderly population showed allele fre-
quencies similar to those of populations of
European origin and different from those of
Japanese samples (11,12). In a Finnish popu-
lation, the R allele frequency did not differ
between newborns and centenarians, indi-
cating the absence of a protective age-re-
lated effect of this allele. The allele frequen-
cies also did not differ among North Ameri-
can adults, Mexican newborns and Finnish
newborns and centenarians (3,4).
Some of the diseases of the subjects
showed gender association, such as obesity
and hypertension in women (Table 1). These
findings agree with those observed among
all residents over 60 in Bambuí, a commu-
nity in Minas Gerais State (28). Another
epidemiological investigation conducted in
the Northeast and Southeast regions of Bra-
zil also showed a higher prevalence of obe-
sity and hypertension among women over
50 years (29).
The comparison between the number of
subjects with R allele with those without R
allele in relation to each morbidity (Table 2)
did not differ significantly as determined by
the chi-square test (data not shown).
Logistic regression analysis did not show
a significant association of the polymor-
phism with morbidity, sex, age, or morbidity
interactions. The absence of association of
this polymorphism with cardiovascular dis-
eases in our Brazilian cohort study con-
firmed findings observed in samples with
similar allele frequencies and differed sig-
nificantly from findings obtained for Japa-
nese samples.
The occurrence of co-morbidities in eld-
erly people is common. In our population
sample we also observed an association of
depression with cardiovascular disease, of
type II diabetes with neoplasia and with
obesity and of depression with dementia.
Major depression is known to be related to
higher cardiovascular mortality as confirmed
in a prospective cohort study of elderly Dutch
men and women and in a study of 12,866
men recruited from the Multiple Risk Factor
Intervention Trial Study (30,31). The asso-
ciation of type II diabetes with pancreatic
carcinoma and breast cancer as well as obe-
sity has been reported (32-34). There are
also reports in the literature on the associa-
tion between depression and dementia (35).
Codon WRN:1367 polymorphism did not
show a significant association with non-in-
sulin-dependent diabetes, as had been re-
ported for a Japanese sample (11).
Investigating WRN polymorphism and
haplotype frequencies in different ethnic
groups certainly strengthens the power of
association and predisposition studies on age-
related morbidities since distinct populations
exhibit different and specific gene frequen-
cies (4,36).
In addition, the functional significance
of Cys/Arg WRN gene polymorphism in age-
related disorders is unknown. It is assumed
that the R allele may confer improved WRN
protein function in the nuclear localization
signal, stability or catalytic activity interac-
tion (7). We are just beginning to understand
the molecular basis of the contribution of
this polymorphism to protein function and
its role in the aging process and pathogen-
esis of age-related diseases.
Our findings, however, do not eliminate
the possibility of WRN gene or other poly-
morphisms and haplotypes playing a role in
the etiopathogenesis of these morbidities.
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